Method for detecting bilirubin in bile and application thereof
By adding water removal agent during bile extraction and combining HPLC and ultraviolet detection, the conversion formula is constructed, which solves the problem of excessive absorption value in bilerubin detection in bile, improves the accuracy and reproducibility of the determination, and achieves the realization of the measurement. More efficient bilirubin detection.
Patent Information
- Application Number
- CN202411121228.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-15
- Publication Date
- 2024-11-22
AI Technical Summary
The existing bilirubin detection methods in bile are prone to the problem of excessive light absorption, resulting in inaccurate measurement values and high requirements for equipment and operation, making it difficult to effectively eliminate interference from other substances.
By adding a water remover to reduce emulsification during bile extraction, combined with HPLC method and ultraviolet method detection, a conversion formula is constructed to correct the absorbance value to obtain more accurate bilirubin content measurement results.
The measurement time of bilirubin is shortened, the accuracy and reproducibility of bilirubin is improved, and the interference of other substances is effectively eliminated, and the problem of excessive absorption value is solved.
Smart Images

Figure BDA0004995159150000061 
Figure BDA0004995159150000071 
Figure BDA0004995159150000081
Abstract
Description
Technical Field
[0001] The invention relates to the field of detection technology, and in particular to a method for detecting bilirubin in bile and an application thereof. Background Art
[0002] Bilirubin is the most abundant pigment in the bile of living organisms. It is mainly produced by hemoglobin, the main component of red blood cells, when old red blood cells are decomposed and metabolized in the bone marrow, thymus, liver, etc. Bilirubin produced from hemoglobin binds to albumin in the blood and is called unconjugated (indirect) bilirubin. Bilirubin that is not bound to other substances is called free bilirubin.
[0003] Determination of free bilirubin in animal bile is an important indicator for measuring the quality standard of animal bile. Bile itself has high medical and commercial value. For example, there are abundant records of bile drugs in traditional Chinese medicine, including bezoar, pig bile, bear bile from mammals, fish bile, snake bile from reptiles, fish, and black class, involving as many as 45 kinds of animals. Records of bile drugs can be traced back to the Han Dynasty. Dog, cow, fish bile and bezoar were recorded as early as in Shennong's Herbal Classic. On this basis, the Famous Doctors' Records added pig and sheep bile, chicken bile and snake bile; it can be seen that animal bile has high medical value. Bear bile, cow bile, pig bile and chicken bile are the raw materials of the corresponding animal bile powder, among which bear bile powder is also called gold in medicine, so animal bile has high commercial value. The 2020 Chinese Pharmacopoeia stipulates that the bilirubin content in natural bezoar should not be less than 25%, and the bilirubin content in in vitro cultured bezoar should not be less than 35%. Ox bile is an important raw material for bilirubin in in vitro cultured bezoar. However, due to its high fat solubility, free bilirubin can easily cross the blood-brain barrier after entering the human body, causing central nervous system toxicity. Therefore, from the perspective of controlling the adverse reactions of animal bile, the determination of free bilirubin has important medical value.
[0004] As methods for determining bilirubin, there are known methods such as ultraviolet method (based on the absorption characteristics of bilirubin molecules under specific wavelengths of ultraviolet light), diazo method (bilirubin is reacted with a diazo reagent, the principle of which is based on the coupling reaction of bilirubin and a diazo reagent under an acidic environment to generate azobilirubin), vanadic acid method, enzyme method, HPLC method (using high performance liquid chromatography technology to separate and detect bilirubin), etc. The HPLC method for determining bilirubin has the advantages of high sensitivity, strong specificity, high accuracy and good repeatability, but has high requirements for equipment and operation. The ultraviolet method is simple to operate, but the problem of too high absorbance value often occurs in the determination of bilirubin, which leads to inaccurate measurement values. Summary of the invention
[0005] In view of the above problems, the present invention provides a method for detecting bilirubin in bile, which can fully and effectively determine the bilirubin in the sample to be tested, eliminate the interference caused by other substances, and solve the problem of excessively high absorbance. The detection method can shorten the determination time of bilirubin and improve the accuracy and reproducibility of bilirubin determination.
[0006] In order to achieve the above object, the present invention provides a method for detecting bilirubin in bile, comprising the following steps:
[0007] Preparation of test sample: taking bile, adding organic solvent, extracting, separating, taking organic phase, adding water removal agent, centrifuging, taking organic phase, filtering, and obtaining test sample;
[0008] Constructing a conversion formula: detecting the test sample by HPLC to obtain the HPLC bilirubin content, detecting the test sample by ultraviolet method to obtain the ultraviolet bilirubin content, and correcting the ultraviolet bilirubin content based on the HPLC bilirubin content to obtain a conversion formula;
[0009] Detection of bilirubin: The sample is processed by the method for preparing the test sample, and detected by ultraviolet method to obtain the absorbance value, and the absorbance value is substituted into the conversion formula to obtain the bilirubin content.
[0010] During the research, the inventors found that the reason why the absorbance value is easily too high is that in the process of extracting bilirubin from bile, the lower organic phase and the upper aqueous phase are very likely to emulsify. After further research on the cause of emulsification, the inventors found that because bile contains a high content of surfactant components, including but not limited to bile acid, mucin and other components, after extraction with an organic solvent, the lower organic phase often contains trace amounts of aqueous droplets, which causes the lower organic phase and the upper aqueous phase to be very likely to emulsify, which in turn causes the absorbance value to be too high. Therefore, the inventors proposed that after the organic phase is obtained by separation, a dehydrating agent is added to reduce the occurrence of emulsification. At the same time, the above-mentioned detection method utilizes the characteristics that the bilirubin obtained by extraction can be separated and then detected by HPLC. Based on the HPLC method data, the corresponding correction coefficients of other methods are calculated, so that a simpler detection method can be used in the actual detection process to obtain accurate detection results, and the bilirubin determination time can be shortened, and the accuracy and reproducibility of bilirubin determination can be improved; and the problem that the components of bile are complex and it is not easy to directly load the sample with HPLC is solved.
[0011] In one embodiment, the volume ratio of the bile to the organic solvent is 1:(1-5).
[0012] In one embodiment, in the step of preparing the sample, the dehydrating agent includes at least one of magnesium sulfate, calcium chloride, and magnesium chloride; and the dosage ratio of the bile to the dehydrating agent is (5-15) mL: (2-8) g.
[0013] The above-mentioned dehydrating agents do not react with bilirubin and can adsorb bile acid, mucin and other components to a certain extent, while other dehydrating agents, such as silica gel powder, activated carbon, quicklime, etc., may adsorb bilirubin and reduce the detection effect.
[0014] In one embodiment, in the step of preparing the test sample, the centrifugal speed is 5500-8500 rpm, and the centrifugal time is 3-7 min;
[0015] The filtration is performed using an organic phase filter membrane, and the pore size of the organic phase filter membrane is 22 μm.
[0016] In one embodiment, the bilirubin is free bilirubin.
[0017] In one embodiment, the detection method further includes a step of drawing a standard curve before the step of preparing the test sample, and the step of drawing a standard curve includes: preparing a standard solution, using HPLC to draw a HPLC standard curve of bilirubin, and using UV method to draw a UV standard curve of bilirubin.
[0018] The invention also provides application of the detection method in quality control of traditional Chinese medicines.
[0019] The present invention also provides a quality control method for Chinese medicinal materials, which includes detecting the bilirubin content. The quality control method includes the following steps: adding a sample to be tested to an organic solvent, extracting, separating, taking an organic phase, adding a water removal agent, centrifuging, taking an organic phase, filtering, obtaining a sample to be tested, detecting the sample to be tested by an ultraviolet method, obtaining an absorbance value, substituting the absorbance value into the conversion formula, and obtaining the bilirubin content.
[0020] In one embodiment, the Chinese medicinal material includes at least one of bezoar, pig bile, bear bile, fish bile, snake bile, dog bile, sheep bile, and chicken bile.
[0021] The present invention also provides a system for quality control of Chinese medicinal materials, comprising:
[0022] A data storage module, used for storing data information;
[0023] A data analysis module, used to analyze the Chinese medicinal materials according to the quality control method to obtain the bilirubin content of the sample to be tested; and
[0024] The data display module is used to output and display the bilirubin content of the sample to be tested.
[0025] In one embodiment, the data storage module is used to store the conversion formula and the absorbance value of the sample to be tested; the data analysis module is used to call the absorbance value of the sample to be tested and substitute it into the conversion formula.
[0026] Compared with the prior art, the present invention has the following beneficial effects:
[0027] The present invention discloses a method for detecting bilirubin in bile and its application. The method can fully and effectively determine the bilirubin in the sample to be tested, eliminate the interference caused by other substances, and solve the problem of excessively high absorbance. The method can shorten the determination time of bilirubin and improve the accuracy and reproducibility of bilirubin determination. BRIEF DESCRIPTION OF THE DRAWINGS
[0028] Figure 1 It is the detection flow chart; DETAILED DESCRIPTION
[0029] In order to facilitate the understanding of the present invention, the present invention will be described more fully below with reference to the relevant drawings. The preferred embodiments of the present invention are given in the drawings. However, the present invention can be implemented in many different forms and is not limited to the embodiments described herein. On the contrary, the purpose of providing these embodiments is to make the understanding of the disclosure of the present invention more thorough and comprehensive.
[0030] Unless otherwise defined, all technical and scientific terms used herein have the same meaning as those generally understood by those skilled in the art of the present invention. The terms used herein in the specification of the present invention are only for the purpose of describing specific embodiments and are not intended to limit the present invention. The term "and / or" used herein includes any and all combinations of one or more related listed items.
[0031] source:
[0032] Unless otherwise specified, the reagents, materials, and equipment used in this example are all commercially available; the experimental methods are all conventional experimental methods in the art unless otherwise specified.
[0033] Example 1
[0034] A method for detecting bilirubin in bile.
[0035] The process of the detection method of this embodiment is as follows Figure 1 shown.
[0036] 1. Draw a standard curve.
[0037] 1. Drawing of UV standard curve.
[0038] 1.1 Preparation of stock solution.
[0039] Take 10 mg of bilirubin standard and dilute it into a 100 mL brown volumetric flask with dichloromethane as solvent to prepare a 0.1 mg / mL bilirubin stock solution.
[0040] 1.2 Preparation of standard solution.
[0041] Take 100, 250, 400, 550, 700, 850, 1000 μL of bilirubin stock solution respectively, dilute them into 10 mL volumetric flasks with dichloromethane as solvent, shake up and down to prepare 1-10 μg / mL bilirubin standard solution.
[0042] 1.3 Determine the absorbance value.
[0043] The absorbance was measured at a wavelength of 453 nm and the standard curve was calculated.
[0044] 2. Drawing of HPLC standard curve.
[0045] 2.1 Chromatographic conditions and system suitability test.
[0046] Octadecylsilane bonded silica gel is used as filler, acetonitrile-1% glacial acetic acid solution (95:5) is used as mobile phase, and the detection wavelength is 450nm. The theoretical plate number calculated based on the bilirubin peak should be no less than 3000.
[0047] 2.2 Preparation of reference solution.
[0048] Take an appropriate amount of bilirubin reference substance, weigh it accurately, and add dichloromethane to make a solution containing 1-40 μg per 1 mL.
[0049] 5 μL of the reference solution was taken respectively, and the bilirubin peak was integrated to draw a standard curve.
[0050] 2. Prepare the test sample.
[0051] Take 10mL of ox bile and add 50mL of dichloromethane. Use a disposable 10mL pipette to measure the ox bile and a 50mL glass pipette to measure the dichloromethane to prevent dichloromethane leakage. Perform extraction and let stand for 30 minutes until the layers are separated. Use a separatory funnel to separate the layers to obtain the lower organic phase. Add 5g of CaCl2 to remove moisture and use a centrifuge to centrifuge at 6000rpm and 25℃ for 5 minutes. Pass the lower organic layer through an organic phase filter membrane of 22μm to obtain the free bilirubin test solution.
[0052] 3. Construct a conversion formula.
[0053] The free bilirubin test solution obtained in the previous step was tested for bilirubin content by UV method and HPLC method, respectively, and the result of HPLC method was used for numerical correction to obtain the corresponding conversion formulas.
[0054] 4. Test the sample for bilirubin.
[0055] Take 10mL of bile sample, add 50mL of dichloromethane for extraction, let stand for 30min until the layers are separated, use a separatory funnel to separate the liquid to obtain the lower organic phase, add 5g of CaCl2 to remove moisture, and use a centrifuge to centrifuge at 6000rpm and 25℃ for 5min. The lower organic layer is passed through an organic phase filter membrane of 22μm, and the absorbance of the obtained test solution is measured at a wavelength of 453nm or 533nm, and converted using the conversion formula obtained in the previous step.
[0056] The absorbance value can be measured by any of a compliant visible-ultraviolet spectrophotometer or an enzyme-labeled instrument or other instruments capable of detecting single wavelength absorption light, preferably a visible-ultraviolet spectrophotometer. In this embodiment, the wavelength is 453 nm. In the above-mentioned preparation process of the test sample, ice bath, ultrasound and other steps can be added before extraction.
[0057] Example 2
[0058] A method for detecting bilirubin in bile.
[0059] 1. Draw a standard curve.
[0060] 1. Drawing of UV standard curve.
[0061] 1.1 Preparation of stock solution.
[0062] Take 10 mg of bilirubin standard and dilute it into a 100 mL brown volumetric flask with dichloromethane as solvent to prepare a 0.1 mg / mL bilirubin stock solution.
[0063] 1.2 Preparation of standard solution.
[0064] Take 100, 250, 400, 550, 700, 850, 1000 μL of bilirubin stock solution respectively, dilute them into 10 mL volumetric flasks with dichloromethane as solvent, shake up and down to prepare 1-10 μg / mL bilirubin standard solution.
[0065] 1.3 Determine the absorbance value.
[0066] The absorbance was measured at a wavelength of 453 nm and the standard curve was calculated.
[0067] 2. Drawing of HPLC standard curve.
[0068] HPLC method:
[0069] 2.1 Chromatographic conditions and system suitability test.
[0070] Octadecylsilane bonded silica gel is used as filler, acetonitrile-1% glacial acetic acid solution (95:5) is used as mobile phase, and the detection wavelength is 450nm. The theoretical plate number calculated based on the bilirubin peak should be no less than 3000.
[0071] 2.2 Preparation of reference solution.
[0072] Take an appropriate amount of bilirubin reference substance, weigh it accurately, and add dichloromethane to make a solution containing 1-40 μg per 1 mL.
[0073] 5 μL of the reference solution was taken respectively, and the bilirubin peak was integrated to draw a standard curve.
[0074] 2. Prepare the test sample.
[0075] Take 10mL of ox bile and add 30mL of dichloromethane. Use a disposable 10mL pipette to measure the ox bile and a 50mL glass pipette to measure the dichloromethane to prevent leakage of dichloromethane. Perform extraction and let stand for 20 minutes until the layers are separated. Use a separatory funnel to separate the layers to obtain the lower organic phase. Add 5g of MgSO4 to remove moisture and use a centrifuge to centrifuge at 8000rpm for 5 minutes. Pass the lower organic layer through an organic phase filter membrane of 22μm to obtain the free bilirubin test solution.
[0076] 3. Construct a conversion formula.
[0077] The free bilirubin test solution obtained in the above step is tested for bilirubin content by the UV method and HPLC method in the step, and the result of the HPLC method is used for numerical correction to obtain the corresponding conversion formulas.
[0078] 4. Test the sample for bilirubin.
[0079] Take 10mL of ox bile and add 30mL of dichloromethane. Use a disposable 10mL pipette to measure the ox bile and a 50mL glass pipette to measure the dichloromethane to prevent leakage of dichloromethane. Perform extraction and let stand for 20 minutes until the layers are separated. Use a separatory funnel to separate the layers to obtain the lower organic phase. Add 5g of MgSO4 to remove moisture and use a centrifuge to centrifuge at 8000rpm for 5 minutes. Pass the lower organic layer through an organic phase filter membrane of 22μm. The absorbance of the obtained test solution is measured at a wavelength of 453nm or 533nm, and converted using the conversion formula obtained in the previous step.
[0080] The absorbance value can be measured by any of a compliant visible-ultraviolet spectrophotometer or an enzyme-labeled instrument or other instruments capable of detecting single wavelength absorption light, preferably a visible-ultraviolet spectrophotometer. In this embodiment, the wavelength is 453 nm. In the above-mentioned preparation process of the test sample, ice bath, ultrasound and other steps can be added before extraction.
[0081] Comparative Example 1
[0082] 1. Draw a standard curve
[0083] 1. Drawing of UV standard curve.
[0084] 1.1 Preparation of stock solution.
[0085] Take 10 mg of bilirubin standard and dilute it into a 100 mL brown volumetric flask with dichloromethane as solvent to prepare a 0.1 mg / mL bilirubin stock solution.
[0086] 1.2 Preparation of standard solution.
[0087] Take 100, 250, 400, 550, 700, 850, 1000 μL of bilirubin stock solution respectively, dilute it into a 10 mL volumetric flask with dichloromethane as solvent, shake it up and down to prepare 1-10 μg / mL bilirubin standard solution.
[0088] 1.3 Determine the absorbance value.
[0089] The absorbance was measured at a wavelength of 453 nm and the standard curve was calculated.
[0090] Standard curve: y = 0.106x-0.0159
[0091] R 2 =0.9995
[0092] y: absorbance; x: concentration
[0093] 2. Drawing of HPLC standard curve.
[0094] 2.1 Chromatographic conditions and system suitability test.
[0095] Octadecylsilane bonded silica gel was used as filler, acetonitrile-1% glacial acetic acid solution (95:5) was used as mobile phase, and the detection wavelength was 450 nm. The theoretical plate number was calculated based on the bilirubin peak to be 16685.73, not less than 3000.
[0096] 2.2 Preparation of reference solution.
[0097] Take an appropriate amount of bilirubin reference substance, weigh it accurately, and add dichloromethane to make a solution containing 1-40 μg per 1 mL.
[0098] 5 μL of the reference solution was taken respectively, and the bilirubin peak was integrated to draw a standard curve.
[0099] Standard curve: y = 298.44x-0.4471
[0100] R 2 =0.9986
[0101] y: peak area; x: concentration
[0102] 2. Preparation of test samples
[0103] Take 10 mL of ox bile, add 30 mL of dichloromethane for extraction, let stand for 20 min until the layers are separated, use a separatory funnel to separate the layers to obtain the lower organic phase, add 5g MgSO4 / 5g CaCl2 / no dehydrating agent to remove moisture, use a centrifuge to centrifuge at 8000 rpm for 5 min. Pass the lower organic layer through an organic phase filter membrane of 22μm to obtain the free bilirubin test solution.
[0104] 3. Comparative Test
[0105] The free bilirubin test solution was tested for bilirubin content by the bilirubin detection method of the present invention and conventional HPLC method, and the results are shown in the following table.
[0106] Table 1 Test results of free bilirubin content
[0107]
[0108] Liquid HPLC is a relatively accurate testing method commonly used in the art. It is conventionally believed in the art that the value obtained by the liquid HPLC method is the true value of free bilirubin. The results in the above table show that when MgSO4 or CaCl2 is used as a dehydrating agent, the free bilirubin content obtained by the detection method of the present invention is closer to the value obtained by the HPLC method, while when no dehydrating agent is added, the free bilirubin content obtained by the detection method of the present invention far exceeds the value obtained by the HPLC method. The inventors believe that the failure to add a dehydrating agent will cause the sample to emulsify during the extraction process, resulting in a high absorbance value.
[0109] From the results, the effect of adding MgSO4>CaCl2>not adding dehydrating agent, the free bilirubin content measured with MgSO4 as dehydrating agent is closer to the free bilirubin content detected by HPLC, and the effect is better than detecting free bilirubin with CaCl2 as dehydrating agent.
[0110] Experimental example
[0111] 1. Draw a standard curve.
[0112] 1. Drawing of UV standard curve.
[0113] 1.1 Preparation of stock solution.
[0114] Take 10 mg of bilirubin standard and dilute it into a 100 mL brown volumetric flask with dichloromethane as solvent to prepare a 0.1 mg / mL bilirubin stock solution.
[0115] 1.2 Preparation of standard solution.
[0116] Take 100, 250, 400, 550, 700, 850, 1000 μL of bilirubin stock solution respectively, dilute them into 10 mL volumetric flasks with dichloromethane as solvent, shake up and down to prepare 1-10 μg / mL bilirubin standard solution.
[0117] 1.3 Determine the absorbance value.
[0118] The absorbance was measured at a wavelength of 453 nm and the standard curve was calculated.
[0119] Standard curve: y = 0.106x-0.0159
[0120] R 2 =0.9995
[0121] y: absorbance; x: concentration
[0122] 2. Drawing of HPLC standard curve.
[0123] 2.1 Chromatographic conditions and system suitability test.
[0124] Octadecylsilane bonded silica gel was used as filler, acetonitrile-1% glacial acetic acid solution (95:5) was used as mobile phase, and the detection wavelength was 450nm. The theoretical plate number was calculated based on the bilirubin peak to be 16685.73, not less than 3000.
[0125] 2.2 Preparation of reference solution.
[0126] Take an appropriate amount of bilirubin reference substance, weigh it accurately, and add dichloromethane to make a solution containing 1-40 μg per 1 mL.
[0127] 5 μL of the reference solution was taken respectively, and the bilirubin peak was integrated to draw a standard curve.
[0128] Standard curve: y = 298.44x-0.4471
[0129] R 2 =0.9986
[0130] y: peak area; x: concentration
[0131] 2. Preparation of test samples
[0132] Take 10mL of ox bile and add 30mL of dichloromethane. Extract, let stand for 20min until stratification, use a separatory funnel to separate the liquid to obtain the lower organic phase, add 5g of MgSO4 to remove moisture, and use a centrifuge to centrifuge at 8000rpm for 5min. Pass the lower organic layer through an organic phase filter membrane of 22μm to obtain the free bilirubin test solution.
[0133] 3. Constructing the conversion formula
[0134] The free bilirubin test solution obtained in the above step was used to determine the bilirubin content of different batches of bovine bile by the UV method and HPLC method in the step, and the test results are shown in the following table.
[0135] Table 2 Test results of bilirubin content in different batches of cattle bile
[0136]
[0137]
[0138] Conversion formula:
[0139] Free bilirubin content: c (HPLC) =C (紫外) / K
[0140] where c (HPLC) For the accurate free bilirubin content.
[0141] c (紫外) The free bilirubin content was measured by UV method
[0142] In this experimental example, MgSO4 was used as a dehydrating agent to treat different batches of bovine bile, and the bilirubin content in the bile was detected. The results obtained were all excellent, indicating that the detection method of the present invention has good stability for different batches of bovine bile.
[0143] The technical features of the above-described embodiments may be arbitrarily combined. To make the description concise, not all possible combinations of the technical features in the above-described embodiments are described. However, as long as there is no contradiction in the combination of these technical features, they should be considered to be within the scope of this specification.
[0144] The above-mentioned embodiments only express several implementation methods of the present invention, and the descriptions thereof are relatively specific and detailed, but they cannot be understood as limiting the scope of the invention patent. It should be pointed out that, for ordinary technicians in this field, several variations and improvements can be made without departing from the concept of the present invention, and these all belong to the protection scope of the present invention. Therefore, the protection scope of the patent of the present invention shall be subject to the attached claims.
Claims
1. A method for detecting bilirubin in bile, characterized in that: The following steps are involved: Preparation of test sample: taking bile, adding organic solvent, extracting, separating, taking organic phase, adding water removal agent, centrifuging, taking organic phase, filtering, and obtaining test sample; Constructing a conversion formula: detecting the test sample by HPLC to obtain the HPLC bilirubin content, detecting the test sample by ultraviolet method to obtain the ultraviolet bilirubin content, and correcting the ultraviolet bilirubin content based on the HPLC bilirubin content to obtain a conversion formula; Detection of bilirubin: The sample is processed by the method for preparing the test sample, and detected by ultraviolet method to obtain the absorbance value, and the absorbance value is substituted into the conversion formula to obtain the bilirubin content.
2. The detection method according to claim 1, characterized in that: In the step of preparing the sample, the dehydrating agent includes at least one of magnesium sulfate, calcium chloride, and magnesium chloride; the dosage ratio of the bile to the dehydrating agent is (5-15) mL: (2-8) g.
3. The detection method according to claim 1, characterized in that: In the step of preparing the test sample, the centrifugal speed is 5500-8500 rpm, and the centrifugal time is 3-7 min; The filtration is performed using an organic phase filter membrane, and the pore size of the organic phase filter membrane is 22 μm.
4. The detection method according to claim 1, characterized in that: The bilirubin is free bilirubin.
5. The detection method according to any one of claims 1 to 4, characterized in that: The detection method also includes a standard curve drawing step before the test sample preparation step, and the standard curve drawing step includes: preparing a standard solution, using HPLC to draw a HPLC standard curve of bilirubin, and using UV method to draw a UV standard curve of bilirubin.
6. Application of the detection method according to any one of claims 1 to 5 in the quality control of traditional Chinese medicines.
7. A method for quality control of Chinese medicinal materials, characterized in that: The quality control includes detecting the bilirubin content, and the quality control method includes the following steps: adding an organic solvent to a sample to be tested, extracting, separating, taking an organic phase, adding a water removal agent, centrifuging, taking an organic phase, filtering, obtaining a sample to be tested, detecting the sample to be tested by an ultraviolet method, obtaining an absorbance value, substituting the absorbance value into a conversion formula described in any one of claims 1 to 5, and obtaining the bilirubin content.
8. The quality control method according to claim 7, characterized in that: The Chinese medicinal materials include at least one of bezoar, pig bile, bear bile, fish bile, snake bile, dog bile, sheep bile and chicken bile.
9. A system for quality control of Chinese medicinal materials, characterized in that: include: A data storage module, used for storing data information; A data analysis module, used to analyze the Chinese medicinal materials according to the quality control method according to any one of claims 7-8 to obtain the bilirubin content of the sample to be tested; and The data display module is used to output and display the bilirubin content of the sample to be tested.
10. The system according to claim 9, characterized in that The data storage module is used to store the conversion formula described in any one of claims 1 to 5 and the absorbance value of the sample to be tested; the data analysis module is used to call the absorbance value of the sample to be tested and substitute it into the conversion formula.
